Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/18556

Title: Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis
Authors: Janssens, Kris
Van den Haute, C.
Baekelandt, Veerle
Lucas, S.
Van Horssen, Jack
Van Wijmeersch, Bart
Stinissen, Piet
Hellings, Niels
Hendriks, Jerome
Slaets, Leen
Somers, Veerle
Issue Date: 2015
Citation: BRAIN BEHAVIOR AND IMMUNITY (45), p. 180-188
Abstract: Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS), for which current treatments are unable to prevent disease progression. Based on its neuroprotective and neuroregenerating properties, leukemia inhibitory factor (LIF), a member of the interleukin-6 (IL-6) cytokine family, is proposed as a novel candidate for MS therapy. However, its effect on the autoimmune response remains unclear. In this study, we determined how LIF modulates T cell responses that play a crucial role in the pathogenesis of MS. We demonstrate that expression of the LIF receptor was strongly increased on immune cells of MS patients. LIF treatment potently boosted the number of regulatory T cells (Tregs) in CD4+ T cells isolated from healthy controls and MS patients with low serum levels of IL-6. Moreover, IL-6 signaling was reduced in the donors that responded to LIF treatment in vitro. Our data together with previous findings revealing that IL-6 inhibits Treg development, suggest an opposing function of LIF and IL-6. In a preclinical animal model of MS we shifted the LIF/IL-6 balance in favor of LIF by CNS-targeted overexpression. This increased the number of Tregs in the CNS during active autoimmune responses and reduced disease symptoms. In conclusion, our data show that LIF downregulates the autoimmune response by enhancing Treg numbers, providing further impetus for the use of LIF as a novel treatment for MS and other autoimmune diseases.
Notes: Hellings, N (reprint author), Hasselt Univ, Biomed Res Inst, Dept Immunol, Agoralaan Bldg C, B-3590 Diepenbeek, Belgium. niels.hellings@uhasselt.be
URI: http://hdl.handle.net/1942/18556
DOI: 10.1016/j.bbi.2014.11.010
ISI #: 000350523800019
ISSN: 0889-1591
Category: A1
Type: Journal Contribution
Validation: ecoom, 2016
Appears in Collections: Research publications

Files in This Item:

Description SizeFormat
published version2.26 MBAdobe PDF

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.